Company attributes
Location
Pitchbook URL
Founded Date
2016
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Closed
Arkin Bio Ventures is a Tel Aviv, Israel based venture capital firm founded in 2016. It is a part of Arkin Holdings.
The firm prefers to invest and support early and mid-stage companies that focus on immunotherapy, cancer, metabolism, microbiome, autoimmune diseases, and drug delivery platforms.
The notable investment portfolio of Arkin Bio Ventures includes ARTSaVIT, Keros Therapeutics, Metabomed, Oncorus, Pi Therapeutics, Werewolf Therapeutics. As of January 2020, Arkin Bio Ventures has made 10 investments.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
